While Lupin will market empagliflozin under the brand name of Gibtulio, Boehringer Ingelheim will continue to sell it under Jardiance brand in India
Acquisition will help Intas to strengthen its presence in European healthcare sector, one of its key overseas markets
This is one of several actions taken to reduce operating costs as the company faces a challenging competitive environment in 2017, especially in its large US market
The Ahmedabad-based pharma major will lead the development of the novel compound, which was discovered by MMV in collaboration with AstraZeneca, India
The funds will be used for phase II development and manufacturing of an inactivated Zika vaccine
The acquisition will enhance Cambrex's portfolio of small molecule API services and complements its existing large scale, multi-purpose manufacturing facilities in the US and Europe
In May 2016, the US-based pharma major entered into an agreement with Piramal Enterprises to sell its four products for a total consideration of Rs 110 crores
Partnership will enable Novasep to offer early-stage solid-state chemistry services in North America
The approved product is the generic version of Abbvie Inc's Zemplar injection
As per the deal, the company will market and distribute Amgen's three medicines in India in the therapy areas of oncology and osteoporosis
The company stands to receive up to $ 610 million through 2021 if US Biomedical Advanced Research and Development Authority (BARDA) exercises all options
Form 483s were issued after the US drug regulator inspected the company's Goa plant II in connection with ANDA filings for injectable
Mitsubishi Tanabe Pharma Corporation will market and distribute 14 brands, which were acquired by Sun Pharma earlier this year from Novartis Pharma KK
The approved product - telmisartan tablet - is a generic version of Boehringer Ingelheim Pharmaceuticals' Micardis tablet
The expansion, which will take place over the next 10 years, will significantly increase Fresenius Kabi's capacity to produce injectable generic pharmaceuticals
The company has received an Establishment Inspection Report (EIR) from the US drug regulator for its topical manufacturing facility located at Changodar (Ahmedabad)
Acquisition of Anda Inc, the fourth largest distributor of generic pharmaceuticals in the US, will significantly strengthen Teva's extensive supply chain network in the US
The approved product, linezolid injection 600 mg/300 mL (2 mg/mL), has an estimated market size of $ 87 million for the twelve months ending June 2016, according to IMS
With the acquisition of Melgain, used for the treatment of vitiligo, Zydus will strengthen its position in the Rs 6000 crore dermatology market
The approved product, omeprazole and sodium bicarbonate powder for oral suspension, is a bioequivalent generic version of Salix Pharmaceuticals' Zegerid powder